OpenVSafe by OpenVAERS
Search V-safe

6ZK-25863-00645

3 vaccinations 2 coded responses 15 check-ins 2 free-text entries 0 call cases
Sex
Female
Age at first dose
26-30
ZIP prefix
928 / CA
Registered
2021-08-01
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-15
    Dose 1 — Pfizer-BioNTech
  2. 2021-02-05
    Dose 2 — Pfizer-BioNTech
  3. 2021-08-01
    Registered in v-safe
  4. 2021-08-08
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  5. 2021-09-27
    Dose 3 — Pfizer-BioNTech
  6. 2021-09-28
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  7. 2021-09-29
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  8. 2021-09-30
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Headache
    Adult check-in
  9. 2021-10-01
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  10. 2021-10-02
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  11. 2021-10-04
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  12. 2021-10-11
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  13. 2021-10-18
    Survey response — day 21, dose 3
    MedDRA: Lacrimation increased, Nasopharyngitis, Rhinorrhoea — Feeling: Fair
    Free text: Running nose and watery eyes. I caught a cold.
    MedDRA releases: 2024-11 · check-in free text available
  14. 2021-10-25
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  15. 2021-11-01
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  16. 2021-11-10
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  17. 2021-12-27
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  18. 2022-03-28
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  19. 2022-09-27
    Survey response — 12 months, dose 3
    MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Covid 19
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-01-15Pfizer-BioNTech No
22021-02-05Pfizer-BioNTech No
32021-09-27Pfizer-BioNTech No

Free text

Release 10 — day 21, dose 3

2021-10-18

Symptoms: Running nose and watery eyes. I caught a cold.

Release 12 — 12 months, dose 3

2022-09-27

Symptoms: Covid 19

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCOVID-19 · · ✓
SDLacrimation increased · · ✓
SDNasopharyngitis · · ✓
SDRhinorrhoea · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release